IRIS
MILANESE, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.156
AS - Asia 3.203
NA - Nord America 2.022
SA - Sud America 242
AF - Africa 52
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 25.684
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.659
US - Stati Uniti d'America 1.888
SG - Singapore 1.338
CN - Cina 879
VN - Vietnam 580
FR - Francia 182
BR - Brasile 149
BD - Bangladesh 109
HK - Hong Kong 104
FI - Finlandia 88
MX - Messico 52
GB - Regno Unito 51
CA - Canada 49
AR - Argentina 46
DE - Germania 41
JP - Giappone 38
ID - Indonesia 27
IQ - Iraq 20
PL - Polonia 17
ZA - Sudafrica 17
CH - Svizzera 16
IN - India 16
PH - Filippine 13
RU - Federazione Russa 13
UA - Ucraina 13
NL - Olanda 12
SA - Arabia Saudita 11
CO - Colombia 10
IE - Irlanda 10
JM - Giamaica 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 9
EC - Ecuador 9
ES - Italia 9
PY - Paraguay 8
DZ - Algeria 7
PK - Pakistan 7
SE - Svezia 7
VE - Venezuela 7
AU - Australia 6
BO - Bolivia 5
CL - Cile 5
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
SI - Slovenia 5
TR - Turchia 5
CR - Costa Rica 4
KE - Kenya 4
KR - Corea 4
MY - Malesia 4
NI - Nicaragua 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
AT - Austria 3
GR - Grecia 3
HN - Honduras 3
MD - Moldavia 3
SN - Senegal 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BE - Belgio 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
KZ - Kazakistan 2
MK - Macedonia 2
MT - Malta 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
Totale 25.677
Salva come PNG Salva come JPEG
Città #
Genova 9.343
Genoa 6.825
Vado Ligure 1.683
Rapallo 1.492
Singapore 689
San Jose 667
Ashburn 199
Ho Chi Minh City 185
Lauterbourg 155
Beijing 135
Hanoi 128
New York 104
Council Bluffs 99
Hong Kong 98
Helsinki 83
Los Angeles 49
Rome 43
Santa Clara 42
Bordighera 40
Tokyo 32
Da Nang 31
Frankfurt am Main 30
Orem 30
Haiphong 29
Milan 29
São Paulo 27
Mexico City 26
Montreal 20
Tianjin 17
Atlanta 16
Zurich 16
Basingstoke 15
Buffalo 14
Chicago 14
Kyiv 13
Turin 13
Baghdad 12
Boardman 12
Biên Hòa 11
Dallas 11
Hải Dương 11
Piscataway 11
St Louis 11
Toronto 11
Dublin 10
Johannesburg 10
Phoenix 10
Warsaw 10
Amsterdam 9
Denver 9
Kingston 9
Naples 9
Phủ Lý 9
Bologna 8
Can Tho 8
London 8
Jakarta 7
Paris 7
Quảng Ngãi 7
Staten Island 7
Buenos Aires 6
Denton 6
Messina 6
Thái Bình 6
Amman 5
Bari 5
Brooklyn 5
Bắc Ninh 5
Charlotte 5
Guayaquil 5
Hamden 5
Houston 5
Jeddah 5
Lappeenranta 5
Ljubljana 5
Madrid 5
Marseille 5
Padua 5
Querétaro 5
Rio de Janeiro 5
Salt Lake City 5
Tampa 5
Tân Tiến 5
Winnipeg 5
Zhengzhou 5
Birmingham 4
Bến Tre 4
Chongqing 4
Cincinnati 4
City of London 4
Dubai 4
Guangzhou 4
Jacksonville 4
Jersey City 4
Krakow 4
Managua 4
Nairobi 4
Nha Trang 4
Poplar 4
Quito 4
Totale 22.847
Salva come PNG Salva come JPEG
Nome #
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 238
Acute stress increases depolarization-evoked glutamate release and presynaptic SNARE complex accumulation in prefrontal/frontal cortex. The dampening action of antidepressants. 236
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 231
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 227
Altered intracellular calcium homeostasis underlying enhanced glutamatergic transmission in striatal-enriched tyrosine phosphatase (STEP) knockout mice 226
CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice 214
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease 209
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 205
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease. 203
Chronic mild stress induces anhedonic behavior and changes in glutamate release, BDNF trafficking and dendrite morphology only in stress vulnerable rats. The rapid restorative action of ketamine 197
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS 193
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. 192
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 190
The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release 184
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 183
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 179
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone 174
Colocalization of neurotransmitter transporters on the plasma membrane of the same nerve terminal may reflect cotransmission. 173
The high-mobility group box 1 cytokine induces transporter-mediated release of glutamate from glial subcellular particles (gliosomes) prepared from in situ-matured astrocytes 171
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 171
Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. 170
Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann glia 170
Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by ‘pathologically’ elevated extraterminal K+ concentrations 166
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 166
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. 166
Synthesis and evaluation of resins bearing substrate-like inhibitor functions for capturing copper amine oxidases 165
Metabotropic glutamate receptor 5 as a potential target in ALS 164
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 162
Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord 160
A New Function for Glycine GLYT2 Transporters: Stimulation of GABA Release from Cerebellar Nerve Terminals Through GAT-1 Transporter Reversal and Ca2+-Dependent Anion Channels 160
The P2X7 receptor as a route for non-exocytotic glutamate release: dependence on the carboxyl tail 159
Excessive and precocious glutamate release in the spinal cord of a mouse model of amyotrophic lateral sclerosis 159
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 158
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 158
Abnormal and precocious exocytotic glutamate release in a mouse model of amyotrophic lateral sclerosis 157
Amyotrophic lateral sclerosis and excitotoxicity: role of Group I metabotropic glutamate receptors 156
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex 155
Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals 154
Glutamate release from astrocytic gliosomes under physiological and pathological conditions 153
Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain 153
Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice 152
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 151
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein 151
CCL5-glutamate crosstalk and presynaptic defects in EAE mice 150
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosisat a Pre-Symptomatic Stage of the Disease. 150
Adult astroglia is competent for Na+/Ca2+ exchanger-operated exocytotic glutamate release triggered by mild depolarization 149
Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis 146
mGluR1 and mGluR5 knock-down improves survival, motor skills and disease progression in amyotrophic lateral sclerosis mouse model 145
Astrocyte contribution to the excessive glutamate release in the spinal cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis 145
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 145
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome. 144
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 144
Targeting Group I Metabotropic Glutamate Receptors in Amyotrophic Lateral Sclerosis 142
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 142
Role of calpain-1 in the early phase of experimental ALS 142
DIABETIC NEUROPATHIC PAIN: A ROLE FOR TESTOSTERONE METABOLITES 141
Unusual increase in lumbar network excitability of the rat spinal cord evoked by the PARP-1 inhibitor PJ-34 through inhibition of glutamate uptake. 141
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis 141
Group I metabotropic glutamate receptors tune excitotoxicity in amyotrophic lateral sclerosis 140
Abnormal glutamate release induced by group I metabotropic glutamate receptors in experimental ALS. 140
In vitro Evidence of Abnormal Glutamate to Glutamine Conversion in Astrocytes harvested from a Mouse Model of Amyotrophic Lateral Sclerosis: a potential Experimental Application of N-13-ammonia 140
Acute stress and corticosterone increase the readily releasable pool of glutamatergic vesicles in rat synaptosomes of prefrontal/frontal cortex via mineralocorticoid and glucocorticoid receptors 139
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone. 138
Neurounina-1, a Novel Compound that Increases Na+/Ca2+ Exchanger Activity, Effectively Protects Against Stroke Damage 138
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 137
Agomelatine reduces glutamate release induced by acute stress, possible synergism between melatonin and 5HT2C properties 136
Acute ketamine restores deficits in glutamate release and related molecular mechanisms induced by chronic mild stress in vulnerable rats 136
GroupI metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 135
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice 135
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 134
Environmental therapy for cognitive and sensory impairment in a mouse model of Down syndrome 134
GROUP I METABOTROPIC GLUTAMATE RECEPTORS AND NEUROTOXICITY IN AMYOTROPHIC LATERAL SCLEROSIS 134
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cells 134
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 133
A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism 133
The GABAergic-like system in the cyprid of Balanus amphitrite (=Amphibalanus amphitrite) (Cirripedia, Crustacea) 132
Cognitive impairment in Gdi1 deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training 132
Release of [3H]D-aspartate induced by K+-stimulation is increased in the cervical spinal cord of wobbler mice, a model of motor neuron disease. 131
Altered synaptic mechanisms and excessive glutamate release in amyotrophic lateral sclerosis 131
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 130
Exosome-shuttled miRNAs derived from mesenchymal stem cells modulate in-vitro the reactive phenotype of amyotrophic lateral sclerosis glial cell 130
Synaptic mechanisms underlying the excessive and precocious glutamate release in the spinal cord of sod1g93a mice. 129
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 129
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 129
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings 127
Molecular mechanisms supporting abnormal glutamate release in the spinal cord of a mouse model of Amyotrophic Lateral Sclerosis. 127
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice 127
Knocking-down mGlu1 receptors prolongs survival and ameliorates disease progression in the SOD1/G93A mouse model of ALS. 126
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex 126
Targeting group i metabotropic glutamate receptors in experimental als. 126
Group I metabotropic glutamate receptors in ALS: knocking-down mGlu1 receptors ameliorates survival and disease progression in SOD1/G93A mice. 125
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 125
TPP-Based Nanovesicles Kill MDR Neuroblastoma Cells and Induce Moderate ROS Increase, While Exerting Low Toxicity Towards Primary Cell Cultures: An In Vitro Study 124
The Modulation of Glutamate Release by Group I Metabotropic Glutamate Auto-Receptors in ALS 123
Increased [3H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse. 123
Group I metabotropic glutamate receptors modulate glutamate exocytosis in a mouse model of als 123
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis 123
Gamma-amino butyric acid (GABA) release in the ciliated protozoon Paramecium occurs by neuronal-like exocytosis 122
Non conventional activity of the endocannabinoid system at glutamate release in rat cortical astrocytes 122
Group I metabotropic glutamate receptors induce excessive glutamate release in the spinal cord of sod1g93a mice 122
Totale 15.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.075
article - articoli 39.193
book - libri 1.089
conference - conferenze 41.793
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.150
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202197 0 0 0 0 0 0 0 0 0 0 0 97
2021/20221.900 37 119 108 191 79 148 123 470 107 173 69 276
2022/20231.838 187 169 23 206 274 289 12 116 295 14 212 41
2023/20241.510 50 175 49 178 124 302 119 67 65 70 108 203
2024/20254.530 218 307 124 307 501 425 384 803 131 200 522 608
2025/20268.607 1.033 242 547 662 1.352 614 1.270 500 732 889 540 226
Totale 26.322